Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BY 4.0BMC Cardiovascular Disorders

ABO blood groups in relation to biomarkers of vascular structure and function in young, healthy adults – the LBA study

  1. 1Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden
  2. 2Department of Laboratory Medicine, Clinical Chemistry, Örebro University Hospital, Örebro, Sweden
  3. 3School of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Abstract

Background: In the elderly, ABO blood groups influence the risk of cardiovascular and thrombotic events, with blood group O consistently showing a more favorable risk profile. However, whether these differences affect physiological markers of vascular structure or subclinical metabolic traits in early adulthood remains poorly studied.

Methods: In this cross-sectional study, cardiovascular disease-related biomarkers in serum, measures of vascular structure and function, pulse-wave velocity (PWV), augmentation index (AIx), carotid intima-media thickness (cIMT), and ABO blood groups were assessed in a sample of young, healthy subjects aged 18–26 years.

Results: No statistically significant differences in PWV, AIx, or cIMT were identified across the different ABO blood groups. Conversely, the serum biomarkers showed distinct profiles. Individuals with blood group O presented with lower plasma concentrations of von Willebrand factor (vWF) compared to all non-O carriers (0.84 kIE/L vs. non-O, 1.09 kIE/L, p < 0.05). Furthermore, blood group O carriers demonstrated significantly lower fasting plasma glucose levels (4.96 mmol/L vs. 5.02 mmol/L, p = 0.02) and a trend toward lower fasting serum insulin levels (p = 0.07).

Conclusion: ABO blood groups were not associated with measures of vascular structure and function in young, healthy adults. Non-O blood groups were associated with higher vWF levels and altered glucose metabolism, suggesting that circulating cardiometabolic risk markers vary by blood group early in life.

Related

  1. Dietary and Circulating Advanced Glycation End Products in Relation to Inflammation and Cognitive Function in Healthy Young Adults
    Mevra Aydin Cil, Neva Karatas, Fatma Betül Ozgeris +3
    NutrientsPeer-reviewedCC BY 4.0Full textNutritionCrossrefEurope PMC
  2. Early Structure–Function Correlates in Neovascular Age-Related Macular Degeneration Using Artificial Intelligence–Derived OCT Biomarkers
    Virginia Mares, Stefan Sacu, Sophie Frank-Publig +17
    Ophthalmology SciencePeer-reviewedCC BY-NC-NDGeneral biologyGeneral medicineHAL
  3. CSF Alzheimer's Disease Biomarkers in Relation to Functional Status and Tofersen Treatment Response in ALS
    F. Eberle, S. Bersen, F. Rachel +3
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
  4. The role of vascular resistance on coronary perfusion: differences between healthy and anomalous coronary origin under rest and exercise conditions
    Seyyed Mahmoud Mousavi, Gianluca Zitti, Marco Pozzi +1
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefPMC
  5. Physical and lifestyle predictors of vascular function in postmenopausal East Asian women: the women’s vascular health project
    Wei Xiong, Fei Tang, Beck Graefe +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineCrossref
BibTeX
@article{stefansson2026blood,
  title = {{ABO blood groups in relation to biomarkers of vascular structure and function in young, healthy adults – the LBA study}},
  author = {Kristina Stefansson and Gurdeep Chahal and Johan Hultdin and Torbjörn K. Nilsson and Paul Pettersson-Pablo},
  journal = {BMC Cardiovascular Disorders},
  year = {2026},
  month = oct,
  doi = {10.1186/s12872-026-06924-0},
  url = {https://doi.org/10.1186/s12872-026-06924-0},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - ABO blood groups in relation to biomarkers of vascular structure and function in young, healthy adults – the LBA study
AU  - Kristina Stefansson
AU  - Gurdeep Chahal
AU  - Johan Hultdin
AU  - Torbjörn K. Nilsson
AU  - Paul Pettersson-Pablo
PY  - 2026
DA  - 2026/10/27
JO  - BMC Cardiovascular Disorders
DO  - 10.1186/s12872-026-06924-0
UR  - https://doi.org/10.1186/s12872-026-06924-0
AB  - Background: In the elderly, ABO blood groups influence the risk of cardiovascular and thrombotic events, with blood group O consistently showing a more favorable risk profile. However, whether these differences affect physiological markers of vascular structure or subclinical metabolic traits in early adulthood remains poorly studied.  Methods: In this cross-sectional study, cardiovascular disease-related biomarkers in serum, measures of vascular structure and function, pulse-wave velocity (PWV), augmentation index (AIx), carotid intima-media thickness (cIMT), and ABO blood groups were assessed in a sample of young, healthy subjects aged 18–26 years.  Results: No statistically significant differences in PWV, AIx, or cIMT were identified across the different ABO blood groups. Conversely, the serum biomarkers showed distinct profiles. Individuals with blood group O presented with lower plasma concentrations of von Willebrand factor (vWF) compared to all non-O carriers (0.84 kIE/L vs. non-O, 1.09 kIE/L, p < 0.05). Furthermore, blood group O carriers demonstrated significantly lower fasting plasma glucose levels (4.96 mmol/L vs. 5.02 mmol/L, p = 0.02) and a trend toward lower fasting serum insulin levels (p = 0.07).  Conclusion: ABO blood groups were not associated with measures of vascular structure and function in young, healthy adults. Non-O blood groups were associated with higher vWF levels and altered glucose metabolism, suggesting that circulating cardiometabolic risk markers vary by blood group early in life.
SN  - 1471-2261
ER  -